“Kuhn believes that it’s not likely that novel coronavirus spread directly from bats to humans, but that one or more animals at the market in Wuhan were infected by bats and served as an intermediate host in the transfer of the virus from bats to humans. It’s thought that humans then came in contact with an infected animal, or animals, at the market. How exactly the virus was transmitted is still unknown, but some theories include a human consuming an infected animal or touching an infected animal during the butchering process.”
“Right now, the biggest worry is whether the medical system has enough ventilators and protective equipment to treat patients with Covid-19, the disease caused by the novel coronavirus.
But another troubling shortage is on the horizon: doctors, nurses, and other health care personnel.
As patient demand continues to ramp up nationwide and more health care workers are unable to show up for work, either because they contract the virus or because they have to self-quarantine, doctor shortages are a real possibility”
…
“One solution is to make it easier to bring in doctors and nurses from abroad.”
…
“even before the current crisis, the immigration system made it difficult for foreign doctors and nurses to work in the US and go where they’re needed. Doctors may face long wait times for green cards, restrictions on where they can settle geographically, and limitations on where they can practice while they’re waiting for a green card. Nurses, meanwhile, also face long waits for green cards and can’t come to the US under temporary skilled worker visas.
The implications of a shortage would be devastating, both to overworked personnel and to the patients for whom receiving medical attention could be a life-or-death matter. But it’s a problem that more immigration could easily fix”
…
“Not only does the current system make it exceedingly difficult for doctors to stay in the US long-term, but it also severely restricts where in the US they can go.”
“To progressives, America’s flailing response to the coronavirus pandemic is everything that’s been terrifying about a Donald Trump presidency since his candidacy started gaining steam — dishonesty, disrespect for expertise, lack of focus and attention to detail, all colliding with a genuinely difficult policy problem to create a lethal catastrophe.
It’s sobering, then, to realize that Trump’s approval ratings, while not exactly good, have been steadily rising since mid-March to reach the highest point since the earliest days of his presidency. After an up-and-down associated with the impeachment process followed by the recent decline, he’s now up to about a 45 percent approval rating from around 40 percent at the beginning of November.
But to contextualize this a bit, essentially all incumbent leaders appear to be benefiting from a coronavirus-related bump. Compared to the governors of hard-hit states or the presidents and prime ministers of hard-hit foreign countries, Trump’s bump is actually quite small, amounting to maybe 2 or 3 points. Compare that with foreign leaders like France’s Emmanuel Macron or Germany’s Angela Merkel, who have seen double-digit increases in their approval ratings.
A Siena College poll released Monday showed New York Gov. Andrew Cuomo (D) enjoying a 20-point boost in his approval rating.”
“The survey was done March 20-23, a week after the initial declaration of emergency.”
…
“Republicans are less likely than Democrats to report responding with CDC-recommended behavior, and are less concerned about the pandemic, yet are more likely to support policies that restrict trade and movement across borders as a response to it. Democrats, by contrast, have responded by changing their personal health behaviors, and supporting policies that socialize the costs of testing and treatment. Partisanship is a more consistent predictor of behaviors, attitudes, and preferences than anything else that we measure.”
“The bill, known as the CARES Act, delivers direct payments to most taxpayers, vastly expands unemployment benefits, and makes testing for the virus free, among other provisions. But although unauthorized immigrants are no more immune from the effects of the current crisis, the stimulus bill conspicuously leaves them out in the cold — potentially putting them at greater economic and health risk, and impeding public health efforts to stop the spread of coronavirus.”
…
““Those who cannot obtain relief are likely to continue going out and trying to earn a living, at the risk of themselves and spreading the virus to others,” Theresa Cardinal Brown, director of immigration and cross-border policy at the Bipartisan Policy Institute, told Vox. “The cost of providing this benefit to them has to be weighed against the need to keep up the restrictions to stop the virus spread.””
“Certified N95 respirators are special. Unlike a conventional surgical mask, N95 masks are built so that 95 percent of very small airborne particles can’t get through. These masks also need to be approved by the CDC’s National Institute for Occupational Safety and Health and, depending on the type, the Food and Drug Administration. In order to fulfill those requirements, N95 masks must be constructed so that they seal tightly around one’s mouth and nose, unlike surgical or cloth masks which are loose-fitting.
The United States is now confronted with a shortage of N95 masks for a number of reasons. The masks themselves are difficult to make, in part because they require specialized equipment to meet stringent regulatory standards. Many of the companies that can make the masks are also in China. That supply chain wasn’t prepared for a pandemic, especially one that originated in the same country where many of these masks are produced. And as the novel coronavirus spread throughout China, the country’s government bought its domestically produced masks, ensuring they weren’t exported. That’s made the gap between supply and demand in the US much larger.
In the absence of a pandemic, the US has typically not produced enough of these N95 masks to meet the needs of its own workers. Prestige Ameritech and 3M are the two primary companies that do end-to-end production of medical-grade N95 masks in the US, and both are both ramping up production. Another American company, Honeywell, recently started producing N95 masks at its Rhode Island and Phoenix facilities. Still, these three companies won’t solve our mask shortage.”
“There is no more politics of fiscal prudence in America, just a competition to see who can wag the biggest firehose. While the bodies begin to pile up in New York City and elsewhere, Washington has responded with a massive course of experimental economics.”
“America is suffering from a shortage of almost everything it needs to combat the spread of COVID-19. Hospital beds, ventilators, gloves, and gowns are all in short supply.
That’s particularly true of the N95 masks that help medical professionals avoid catching and spreading the virus as they tend to patients. The N95 designation refers to the ability of these masks to filter out 95 percent of airborne particles.
In early March, the U.S. Department of Health and Human Services (HHS) said that the country’s stockpile of N95 masks was enough to meet about 1 percent of the three billion masks we would need during a true pandemic.”
…
“government regulations are stifling the ability of manufacturers to set up new N95 mask production facilities—handicapping the private sector’s ability to respond to the current crisis.”
…
“The production of N95 masks is regulated by the CDC’s National Institute for Occupational Safety and Health (NIOSH). Prospective makers of N95 masks must submit detailed written applications to NOISH, and send finished products to its Personal Protective Technology Laboratory for testing. NIOSH staff must also personally inspect new manufacturing sites before they’re allowed to start pumping out masks.
Chisholm says regulators have told the Open PPE Project that getting agency approval could take anywhere from 45 to 90 days.”
…
“3M, one of the largest makers of N95 masks, says that it is producing 35 million respirators per month in the U.S. and that within 12 months it plans to double global production capacity to 2 billion masks a year. It also says it is exploring coalitions with other companies to expand mask production further.
Honeywell, another major mask manufacturer, claims it has more than doubled its mask production, according to The New York Times.
That’s a lot of masks, but nowhere near enough to meet the current demands of the country’s medical sector, let alone the demands of other essential workers and volunteers who are out in public right now, potentially dealing with sick people.”